Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients

Journal of Infectious Diseases

Volumn 178, Issue 3, 1998, Pages 626-635

  Roberts, Thomas C ^b   Brennan, Daniel C ^c   Buller, Richard S ^c   Gaudreault Keener, Monique ^c   Schnitzler, Mark A ^c   Sternhell, Kara E ^c   Garlock, Kathryn A ^c   Singer, Gary G ^c   Storch, Gregory A ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b Infect Dis and Int Med Assoc   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 0031658177     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515383     Document Type: Article

References (16)

1. Ho M. Cytomegalovirus infection and indirect sequelae in the immunocom-promised transplant patient. Transplant Proc 1991;23(suppl 1):2-7.
2. Nevins TE, Dunn DL. Use of ganciclovir for cytomegalovirus infection. J Am Soc Nephrol 1992;2:8270-3.
3. Farrugia E, Schwab TR. Management and prevention of cytomegalovirus infection after renal transplantation. Mayo Clin Proc 1992;67:879-90.
4. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, et al. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 1992;53:68-72.
5. Storch GA, Buller RS, Bailey TC, et al. Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients. J Clin Microbiol 1994;32:997-1003.
6. Buller RS, Bailey TC, Ettinger NA, et al. Use of a modified shell-vial culture technique to quantitate CMV viremia in a population of solid-organ transplant recipients. J Clin Microbiol 1992;10:2620-4.
7. Fox JC, Emery VC. Quantification of viruses in clinical material. Rev Med Virol 1992;2:195-204.
8. Landry ML, Ferguson D. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. J Clin Microbiol 1993;31:2851-6.
9. Schafer P, Braun RW, Möhring K, et al. Quantitative determination of human cytomegalovirus target sequences in peripheral blood leukocytes by nested polymerase chain reaction and temperature gradient gel electrophoresis. J Gen Virol 1993;74:2699-707.
10. Fox JC, Griffiths PD, Emery VC. Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J Gen Virol 1992;73:2405-8.
11. Boivin G, Olson CA, Quirk MR, St-Cyr SM, Jordan MC. Quantitation of human cytomegalovirus glycoprotein H gene in cells using competitive PCR and a rapid fluorescence-based detection system. J Virol Methods 1995;51:329-42.
12. Gerna G, Furione M, Baldanti F, Sarasini A. Comparative quantitation of human cytomegalovirus (CMV) in blood leukocytes and plasma of transplant and AIDS patients. J Clin Microbiol 1994;32:2709-17.
13. Secchiero P, Zella D, Crowley RW, Gallo RC, Lusso P. Quantitative PCR for human herpesviruses 6 and 7. J Clin Microbiol 1995:33:2124-30.
14. Zipeto D, Morris S, Hong C, et al. Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes. J Clin Microbiol 1995;33:2607-11.
15. Zipeto D, Baldanti F, Zella D, et al. Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immuno-compromised patients by the polymerase chain reaction. J Virol Methods 1993;44:45-56.
16. Gerna G, Baldanti F, Sarasini A, et al. Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. Antimicrob Agents Chemother 1994;38:38-44.